Atlas Trials

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

Clinical trial NCT00589381 · COMPLETED

Trial details

NCT number
NCT00589381
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Start date
2007-08-01
Primary completion
2010-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.